JNJJohnson & Johnson

Median target
$282
calls from the last 12 months
Implied return
+4.4%
median target vs. price
Coverage
22 analysts · 23 calls
updated in the last 12 months
Consensus
15/7/0+15 net
Buy / Hold / Sell

Which analysts are behind JNJ's consensus?

See every current rating, price target and the analysts' track records for Johnson & Johnson — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 22 analysts with calls on JNJ updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

JNJ elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: #32 in Losing attention (0.7× vs usual)

DateSourceWhoActionDetailAmount
2026-09-02InsidersSchmid TimothyEVP, WW Chair, MedTechInsider sale22.5K sh @ $274.74$6.2M
2026-09-02InsidersSchmid TimothyEVP, WW Chair, MedTechInsider sale11.1K sh @ $274.74$3.0M
2026-08-27CongressThomas H. Kean JrNJ-NJ07Salesince trade +1.6%, vs market -2.8%$1K–$15K
2026-08-17InsidersTaubert Jennifer LEVP, WWC. Innovative MedInsider sale15.0K sh @ $263.36$4.0M
2026-08-13InsidersDuato JoaquinCEO and Chairman of the Insider sale102.3K sh @ $261.00$26.7M
2026-08-13InsidersDuato JoaquinCEO and Chairman of the Insider sale21.0K sh @ $262.00$5.5M
2026-08-06InsidersForminard ElizabethEVP, Chief Legal OfficerInsider sale9.3K sh @ $257.75$2.4M
2026-08-06InsidersForminard ElizabethEVP, Chief Legal OfficerInsider sale6.6K sh @ $255.93$1.7M
2026-08-05InsidersDuato JoaquinCEO and Chairman of the Insider sale42.0K sh @ $258.06$10.8M
2026-08-05InsidersDuato JoaquinCEO and Chairman of the Insider sale6.5K sh @ $258.74$1.7M

More: congressional trades on JNJ · insider activity · executive branch · trending